Alimera Sciences (ALIM) Reports Approval of ILUVIEN in Kuwait
Tweet Send to a Friend
Alimera Sciences, Inc. (NASDAQ: ALIM) today announced that ILUVIEN has fulfilled all requirements for registration according to the Pharmaceutical ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE